Johnson, K. P. et al "Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability." Neurology 50.3 (1998): 701-708. Web. 19 Sept2021.